.webp)
Chinese Medical Tech Startup Scores Breakthrough Funding for Ion Radiotherapy Medical Solutions.
Cashim, a startup company developing medical technology, announced that it raised CNY800 million (USD115.2 million) in financing - bringing it to a level of funding to allow them to lead globally ion radiotherapy technology. Investors such as the Zhongguancun Independent Innovation Special Fund, Legend Capital, and an additional investor in Xiamen ITG Group have come together to back Cashim's investment strategy for breaking into global markets by creating an extremely precise "game plan," very similar to a championship-caliber plan in Medicine.
Cashim has positioned itself since 2018 in preparation for this breakthrough by developing China's first medical machine employing heavy ions (ion treatment) in 2019, followed by commercial use in 2020, thus placing them in an elite group of countries within only 4 others that use ion treatment effectively (China, the United States, Japan, and Germany).
Cashim's planning has provided them with significant advantages in the field of medicine over traditional radiotherapy. By delivering heavy ions rather than traditional radiotherapy, Cashim can deliver heavy ions in a highly targeted manner (to the specific area of the body) while minimizing damage to healthy tissue surrounding the target (surgical-type hits).
Cashim has successfully launched six years of technological advancements into a full range of equipment for treating patients with heavy ions, protons and neutrons. The company has placed four machines in service and has treated more than 3,500 patients across 50 different cancer diseases. "We are focused on developing a comprehensive, inclusive, accurate and effective system of ion radiotherapy," the organization stated, confirming their focus on connecting medical resources together via electronic and intelligent technologies.
As they continue to receive funding, it seems Cashim is destined to become one of the top organizations in cancer care everywhere and provide unprecedented change for patients across the entire globe by using effective methods for targeting medicine to specific diseases.
.webp)
.webp)
